News
Displaying 301–310 of 508
-
Offer support to patients with inherited eye diseases
In the PressWhile genetic testing can direct treatment and identify those at risk, it is important to have support available when patients test positive.
-
Returning the favor: Never too late to give back as a premium surgeon
In the PressWhether local or international, through donation of services or funds, there is a way for everyone to give back.
-
Foundation News
Known as Pro-EYS, the study will help researchers design clinical trials for potential therapies
-
FDA Authorizes Stem Cell Clinical Trial for RP in Los Angeles
Research NewsPhase 1/2a human study will evaluate neural progenitors for preserving vision
-
AGTC Announces Development of Stargardt Disease Gene Therapy
Research NewsDual-vector delivery system designed to deliver the large ABCA4 gene
-
Iveric Bio’s Therapy Slows Retinal Degeneration in Phase 2b Trial for Dry AMD
Research NewsZimura inhibits a complement protein known as C5, a component of the immune system that, when overactive, can cause retinal degeneration.
-
ReNeuron Reports Interim Results for Eight Patients with RP in Phase 2a Trial for Stem Cell Therapy
Research NewsThe Foundation funded earlier lab studies that made the clinical trial possible.
-
FDA Approves New Wet AMD Treatment that can be Administered Every Three Months
Research NewsBeovu from Novartis reduces treatment burden for wet AMD patients
-
Foundation News
The program will offer patients with inherited retinal disease no-cost genetic testing and genetic counseling in the United States. Look for updated information on how to participate to be posted in mid-October, with program registration starting shortly thereafter.
-
AGTC Reports Promising Interim Results for XLRP and Achromatopsia Gene Therapy Trials
Research NewsAGTC used Foundation’s My Retina Tracker registry to recruit patients for trials
